Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin specific peptidase 17-like family member 8 (USP17L8) is a predicted member of the deubiquitinating enzyme family, which are cysteine proteases involved in removing ubiquitin moieties from substrate proteins[4]. It is classified as "predicted to enable cysteine-type deubiquitinase activity," but its specific enzymatic activity has not been experimentally validated, and the protein may be catalytically inactive[4]. The gene is located on chromosome 8 and is part of a family of USP17-related genes that are primarily implicated in regulating cellular processes like protein stability and the cell cycle, based on the established functions of other USP17 family members[1][2][4]. However, no direct biological function, disease association, nor any drug interaction has been described for USP17L8 specifically in the biomedical literature as of this time. This entry is considered incorrect as a therapeutic target because the "USP17L8" protein is not experimentally validated as an active enzyme or disease-related target; most functional and mechanistic data available apply to other paralogs in the USP17 family (such as USP17, DUB3/USP17, or related isoforms), but not to USP17L8 directly[2][4]. There is significant risk of conflating the broad, established literature for *USP17* with the much less characterized *USP17L8*. Key notes: - USP17L8 is *predicted* to be a deubiquitinating enzyme but may have no demonstrated enzymatic or disease-modifying role[4]. - It is not currently recognized as a therapeutic target; the name and sequence suggest family association, but actual activity and function are uncertain[2][4]. - Most literature on the USP17 family refers to other paralogs (like USP17/USP17A/USP17B/etc.), not specifically USP17L8[2][4]. - There is no evidence for direct drug targeting, biomarker utility, or known disease linkage for USP17L8.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin specific peptidase 17-like family member 8 (USP17L8).